U.S. Wireless Telecom Stock News

Wondering if UMB Financial at around US$109 per share still offers value or if most of the upside is already on the table? This article walks through what the current price might be implying about the company. The stock has pulled back recently, with a 2.4% decline over the last 7 days and a 14.5% decline over the last 30 days, even though the 1 year return sits at 8.0%. Looking further back, the 3 year return is 96.2% and the 5 year return is 29.3%. Recent coverage has focused on UMB...

Coupang (NYSE:CPNG) is helping U.S. organic food brand Spread The Love enter the South Korean market through its marketplace. The partnership uses Coupang's AI powered fulfillment and export engine to bring American small business products to Korean consumers. The move highlights Coupang's role as a cross border partner for U.S. exporters looking for access to Asian e commerce demand. Coupang, a major South Korean e commerce platform, has drawn attention for its AI infrastructure and...

CONMED (NYSE:CNMD) has exited the gastroenterology market and transferred global distribution rights for certain product lines to Micro-Tech Endoscopy. The company has also appointed Andrew Moller as Interim Chief Financial Officer. For investors watching NYSE:CNMD, these moves come at a time when the share price is around $36.8 and multi year returns have been weak, with the stock down 37.1% over 1 year, 60.8% over 3 years, and 69.5% over 5 years. Stepping away from gastroenterology...

Red Cat Holdings (RCAT) has wrapped up FY 2025 with fourth quarter revenue of about US$26.2 million and a basic EPS loss of US$0.16, alongside trailing twelve month revenue of roughly US$40.7 million and a TTM basic EPS loss of US$0.73. Over the past five reported quarters, the company has seen quarterly revenue range from about US$1.3 million to US$26.2 million. Over the same period, quarterly basic EPS has stayed in loss-making territory between roughly US$0.15 and US$0.33 per share,...

Investors may be wondering whether Wolverine World Wide at US$16.50 still offers value after a strong rebound, or if the easy gains are already behind it. The stock has returned 22.2% over the last year, although the year-to-date return sits at a 9.4% decline, with a 2.4% gain over the last week and an 8.9% decline over the last month. Recent attention on Wolverine World Wide has focused on its brand portfolio, cost structure and balance sheet, as investors weigh how these factors might...

Wondering if Afya's share price reflects its real worth, or if the market is missing something important about this education business. Afya's stock has recently closed at US$14.82, with returns of 9.8% over 7 days and 6.5% over 30 days, while the 1 year return sits at a 16.5% decline and the 3 year return at 50.7%. Recent coverage has focused on Afya's position within the Consumer Services sector and how investors are reassessing growth prospects versus risks in the education space. This...

LKQ Corporation disclosed that director Patrick Berard has declined to stand for re-election and will remain on the board until the company’s 2026 annual stockholders’ meeting expected in May 2026. Coupled with recent quarterly results that beat revenue expectations but missed earnings and guidance, this board change adds another layer to LKQ’s ongoing operational and governance reshaping. Next, we’ll examine how LKQ’s earnings miss and evolving board composition may influence the company’s...

Wondering if AeroVironment’s US$211.35 share price still offers value after a strong run, or if you might be looking at a stock that has already priced in much of its story? The stock has slipped around 0.3% over the last week and 19.6% over the past month, yet it still shows a 17.5% decline year to date and a 68.9% gain over the past year, with a 136.3% result over three years and 84.3% over five years. Recent coverage has focused on AeroVironment’s role within the aerospace and defense...

Wondering if Vertex Pharmaceuticals at around US$458 a share is offering fair value, a bargain, or something in between? This breakdown is built to help you size that up quickly. The stock is up 1.3% year to date, with shorter term moves of a 4.2% decline over the last week and a 4.0% decline over the last month. These moves can change how the market is thinking about both risk and opportunity. Recent headlines have focused on Vertex's position within big pharma and biotech, touching on its...

Plains All American Pipeline recently amended key credit facilities in Canada and advanced its shift toward a pure crude oil operation by selling its NGL business and integrating the newly acquired Cactus III pipeline. This restructuring of both assets and credit arrangements underscores how the company is reshaping its capital structure and operational footprint to prioritize more predictable, crude-focused cash flows and efficiency gains. Next, we’ll examine how Plains All American’s NGL...

IHS Holding Limited recently reported fourth-quarter 2025 results, with sales edging up to US$397.8 million while swinging from a prior-year net income of US$246.5 million to a net loss of US$75.8 million. The shift to a basic loss per share of US$0.23, despite higher continuing-operations earnings per share, points to pressures outside the core tower business. We’ll now examine how this move to a quarterly net loss, alongside only modest revenue growth, affects IHS Holding’s existing...

Lincoln Financial Group (NYSE:LNC) has been recognized as one of the World's Most Ethical Companies by Ethisphere for the fifth consecutive year. The 2026 recognition highlights the company's continued focus on ethics, compliance, and responsible business practices. The accolade reinforces Lincoln Financial's positioning around corporate governance, brand reputation, and stakeholder trust. For investors following insurers and retirement providers, ethics and governance can be just as...

NeoGenomics, Inc. recently announced that its PanTracer LBx liquid biopsy test for advanced solid tumors has secured Medicare coverage under the MolDX LCD for plasma-based genomic profiling, enabling covered access to a blood-based panel that analyzes more than 500 genes from a CLIA-certified lab with a seven-day turnaround. This coverage decision not only broadens access to noninvasive genomic testing for Medicare beneficiaries but also highlights the growing clinical role of liquid biopsy...

Consolidated Water Co. Ltd. has reported full-year 2025 results, with sales of US$132.07 million versus US$133.97 million a year earlier and net income of US$18.34 million versus US$28.24 million, reflecting softer overall profitability. Despite lower total net income and earnings per share, the company’s earnings per share from continuing operations edged higher, highlighting a relatively stronger performance in its ongoing core businesses. We’ll now examine how the lower full-year net...

Medtronic (NYSE:MDT) has agreed to acquire Scientia Vascular, a maker of guidewires and catheters for complex brain procedures. The deal is intended to strengthen Medtronic’s neurovascular portfolio, with a focus on stroke and other brain vessel interventions. This transaction reflects ongoing investment in specialized products for complex neurovascular care. For investors watching Medtronic’s medical device portfolio, this move adds more depth in neurovascular tools that sit alongside its...

Alliant Energy filed a $1b at-the-market equity offering program, signaling a sizeable new capital raise. The program allows the company to issue new shares over time into the open market rather than in a single offering. This move comes as Alliant Energy (NasdaqGS:LNT) continues to invest around large data center customers and recent expansion initiatives. Alliant Energy (NasdaqGS:LNT) is coming off a period where the share price is $71.32 and the stock is up 8.7% year to date and 15.8%...

Why a U.S. court decision matters for Burford Capital (BUR) shareholders A U.S. Appeals court has temporarily paused efforts to track Argentine assets in the United States tied to a US$16 billion YPF judgment, directly affecting the Burford Capital (BUR) funded creditor group. This pause keeps the long running dispute in a holding pattern. It matters for investors following how Burford’s legal finance exposure to the Argentina and YPF case interacts with its current US$1.8b market value and...

Nelnet recently reported a softer quarter, with revenue falling 8.6% year on year and both revenue and EPS coming in below analyst expectations. Despite the weak quarterly performance, the CEO highlighted that Nelnet achieved record earnings in 2025 and emphasized efforts to strengthen the company’s long-term foundation. Next, we’ll explore how the revenue shortfall versus expectations shapes Nelnet’s investment narrative and what it might mean for investors. The latest GPUs need a type of...

In its latest quarterly report, CRA International posted an 11.6% year-over-year revenue increase, beating analyst forecasts and marking its eighth consecutive annual revenue record, alongside full-year guidance that also exceeded expectations. This combination of stronger-than-anticipated current performance and higher forward revenue guidance highlights how CRA International is currently converting demand for its consulting expertise into sustained top-line momentum. Next, we'll explore...

Clover Health Investments (NasdaqGS:CLOV) subsidiary Counterpart Health released new data on its digital platform’s impact on flu vaccination rates and acute care events. The evidence links use of Counterpart Health’s tools with higher vaccination uptake and fewer hospitalizations among high risk patients. Clover Health activated real time interoperability for claims data as part of Centers for Medicare & Medicaid Services backed health data exchange efforts. Clover Health Investments,...

NOV Inc. (NYSE: NOV) has appointed Sanjay Chowbey to its Board of Directors. Chowbey brings experience in global manufacturing and industrial technology to the board. The appointment adds operational and technology focused expertise to NOV's governance structure. NOV, trading at $18.59, has seen a 13.3% return year to date and a 27.9% return over the past year, with longer term gains of 15.3% over three years and 49.7% over five years. Against that backdrop, the addition of Sanjay Chowbey...

If you are wondering whether Upwork's current share price reflects its true worth, the recent performance offers plenty to think about. Over the short term, the stock has seen a 4.3% decline over 7 days and an 11.1% decline over 30 days, while the year to date return is a 42.8% decline and the 1 year return stands at a 15.6% decline, compared with a 2.8% gain over 3 years and a 73.9% decline over 5 years. These mixed returns come against a backdrop of ongoing attention on online freelancing...

ExlService Holdings (EXLS) recently entered a US$125 million accelerated share repurchase agreement as part of a larger US$500 million buyback plan, drawing fresh attention to how the market is currently valuing the stock. See our latest analysis for ExlService Holdings. The accelerated share repurchase comes after a weak run for the stock, with a 90 day share price return of 28.65% decline and a 1 year total shareholder return of 33.77% decline, even as EXL rolls out new agentic AI solutions...

If you are wondering whether CBRE Group at around US$133 per share looks attractive, the key question is how that price stacks up against what the business might be worth. The stock has returned 1.0% over the past week, is down 5.7% over 30 days and 16.8% year to date, while 1 year and 3 year returns of 2.4% and 93.3% sit alongside a 74.3% return over 5 years. Recent coverage has focused on CBRE Group's role as a global real estate services firm and how investor sentiment toward commercial...